Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 30, 2015 12:38 AM ET

Biotechnology

Company Overview of BioCryst Pharmaceuticals, Inc.

Executive Profile

Nancy June Hutson Ph.D.

Director, Chairman of Corporate Governance & Nominating Committee and Member of Scientific Committee, BioCryst Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 7 different industries.

See Board Relationships
66$131,738

Background

Dr. Nancy June Hutson, Ph.D., served as Senior Vice President of R&D for Groton and New London Campuses at BioCryst Pharmaceuticals, Inc. until March 2006. Dr. Hutson was a Sponsor of the Network of Executive Women, where she served as a mentor for senior women at Pfizer Global Research & Development. She retired from Pfizer, Inc. in 2006 after spending 25 years in several research and leadership positions. Dr. Hutson served as the Director of Pfizer’s largest pharmaceutical ...

Corporate Headquarters

4505 Emperor Boulevard
Durham, North Carolina 27703

United States

Phone: 919-859-1302
Fax: 919-859-1314

Board Members Memberships

Trustee
Director
2006-Present
Director, Chairperson of Development Committee and Member of Compensation Committee
2009-Present
Independent Director, Chairman of Operations Committee and Member of Nominating & Governance Committee
2009-Present
Director, Member of Compensation Committee and Member of Transactions Committee
2012-Present
Director, Chairman of Corporate Governance & Nominating Committee and Member of Scientific Committee

Education

Doctorate
Vanderbilt University
PhD
Vanderbilt University
BA
Illinois Wesleyan University
Doctorate
University of Oxford

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$42,000
Total Calculated Compensation$131,738
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gustav A. Christensen Chief Executive Officer, President and Director
Dyax Corp.
$636.8K
Sijmen de Vries M.D., MBAChief Executive Officer and Member of Management Board
Pharming Group NV
$624.0K
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
$2.0M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$3.6M
Joji Nakayama Chief Executive Officer, President and Representative Director
Daiichi Sankyo Company, Limited
$131.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BioCryst Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.